Medios 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ILM1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.
Show more...
CEO
Mr. Falk Neukirch
Employees
999
Country
United Kingdom
ISIN
DE000A1MMCC8

Listings

0 Comments

Share your thoughts

FAQ

What is Medios stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medios stocks are traded under the ticker ILM1.MU.
How many employees does Medios have?
As of April 12, 2026, the company has 999 employees.
In which sector is Medios located?
Medios operates in the Manufacturing sector.
When did Medios complete a stock split?
Medios has not had any recent stock splits.
Where is Medios headquartered?
Medios is headquartered in Berlin, United Kingdom.